# Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy

> **NCT02869308** · NA · UNKNOWN · sponsor: **Central Hospital, Nancy, France** · enrollment: 100 (estimated)

## Conditions studied

- Angioscintigraphy
- Tomoscintigraphy

## Interventions

- **DRUG:** stannous pyrophosphate
- **DRUG:** Technetium-99m
- **DEVICE:** E-CAM Camera
- **DEVICE:** CZT Semiconductor Camera (D-SPECT)

## Key facts

- **NCT ID:** NCT02869308
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-01
- **Primary completion:** 2018-01
- **Final completion:** 2018-05
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02869308

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02869308, "Determination of Left Ventricular Ejection Fraction Using Cardiac Angioscintigraphy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02869308. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*